Search Results 1171-1180 of 16043 for melatonin receptor agonists

  1. Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment - Mayo Clinic

    The purpose of this study is to determine if an investigational treatment (Maribavir) is safe and effective in treating transplant recipient patients with ...

  2. A Study to Evaluate Electrophysiology of Deep Brain Stimulation - Mayo Clinic

    Electrophysiological properties such as spike statistics, power spectral density, spike-field coupling, and phase-amplitude coupling may be correlated to ...

  3. Device Evaluation for Point of Care Anticoagulation Testing - Mayo Clinic

    About this study. The purpose of this study is: To Evaluate and validate the Roche Coaguchek XS Plus analyzer at MCA to replace the ITC Hemochron Jr.

  4. BCL2 Inhibitor Venetoclax With Daratumumab-Lenalidomide-Dexamethasone Or Venetoclax-Rd for Newly Diagnosed Multiple Myeloma - Mayo Clinic

    The purpose of this study is to estimate the recommended phase II dose (RP2D) of venetoclax that can be combined with standard dose Dd combination (Arm A), Rd ...

  5. MC200404, Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

    However, TAS-102 is FDA approved for treatment of metastatic colorectal cancer. The FDA has allowed the use of this combination in this research study.

  6. A multidisciplinary approach to head and neck cancer

    Eric Moore, M.D., Department of Otolaryngology, Head and Neck Surgery, Mayo Clinic: We specialize in rare cancers so that they're common for us. You come and ...

  7. Reversing the trajectory of life - Mayo Clinic

    Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.

  8. A Study of the Safety and Effectiveness of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study of SAR442085 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    About this study. The purpose of this study is to determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with ...

  10. Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405) - Mayo Clinic

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...